Table 2:
Adjusted odds ratios for hospitalization, intensive care unit admission, and death among reported COVID-19 cases*
Variable | Hospitalization OR (95% CI) | ICU admission OR (95% CI) | Death OR (95% CI) |
---|---|---|---|
VOC status | |||
Non-VOC | Ref. | Ref. | Ref. |
Probable Delta variant | 2.08 (1.78–2.40) | 3.35 (2.60–4.31) | 2.33 (1.54–3.31) |
N501Y+ variant | 1.52 (1.42–1.63) | 1.89 (1.67–2.17) | 1.51 (1.30–1.78) |
Sex, male | 1.29 (1.23–1.36) | 1.60 (1.48–1.75) | 1.67 (1.50–1.85) |
Age, yr (per 10-year increase) | 2.07 (2.04–2.10) | 1.96 (1.91–2.01) | 3.46 (3.32–3.59) |
Vaccination status | |||
Nonvaccinated | Ref. | Ref. | Ref. |
Partially vaccinated | 0.42 (0.40–0.44) | 0.28 (0.25–0.30) | 0.09 (0.07–0.10) |
Fully vaccinated | 0.31 (0.23–0.43) | 0.15 (0.04–0.30) | 0.21 (0.10–0.35) |
Comorbidity† | 2.76 (2.59–2.95) | 2.58 (2.28–2.90) | 2.40 (2.08–2.71) |
Pregnant | 6.26 (4.56–8.43) | 6.85 (3.59–10.80) | – |
Series week‡ | 0.99 (0.99–1.00) | 0.98 (0.97–0.99) | 0.96 (0.95–0.98) |
Note: CI = confidence interval, ICU = intensive care unit, OR = odds ratio, VOC = variant of concern.
We treated health units as random effects in models.
Comorbidities include 1 or more of asthma, chronic obstructive pulmonary disease, hematological disease, liver disease, cardiac disease, diabetes, immune compromise, renal disease, neurologic disease, malignancy, or obesity.
Week from Feb. 7 to June 27, 2021, modelled as a continuous variable.